Comparative effects of intranasal neuropeptide Y and HS014 in preventing anxiety and depressive-like behavior elicited by single prolonged stress.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Behavioural Brain Research

• Publication date

  2015-12-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.bbr.2014.12.038PMID 25542511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model.

  2014cited by this paper
• Blockage of melanocortin‐4 receptors by intranasal HS014 attenuates single prolonged stress‐triggered changes in several brain regions

  2014cited by this paper
• Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies.

  2014cited by this paper
• Early intervention with intranasal NPY prevents single prolonged stress-triggered impairments in hypothalamus and ventral hippocampus in male rats.

  2014cited by this paper
• Loss of melanocortin-4 receptor function attenuates HPA responses to psychological stress.

  2014cited by this paper
• Synaptic changes induced by melanocortin signalling

  2014cited by this paper
• Neuropeptide Y and posttraumatic stress disorder

  2013cited by this paper
• Role of neuropeptides in anxiety, stress, and depression: from animals to humans.

  2013cited by this paper
• Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats.

  2013cited by this paper
• Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress.

  2013cited by this paper
• The link between stress and feeding behaviour.

  2012cited by this paper
• EARLY INTERVENTIONS FOR PTSD: A REVIEW

  2012cited by this paper
• Pavlovian fear memory circuits and phenotype models of PTSD.

  2012cited by this paper
• Molecular mechanisms of fear learning and memory.

  2011cited by this paper
• In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma.

  2011cited by this paper
• The role of norepinephrine in differential response to stress in an animal model of posttraumatic stress disorder.

  2011cited by this paper
• High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interplay between clinical and animal studies.

  2011cited by this paper
• Prevention of posttraumatic stress disorder.

  2011cited by this paper
• Adaptation to extreme stress: post-traumatic stress disorder, neuropeptide Y and metabolic syndrome

  2010cited by this paper
• CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD.

  2010cited by this paper
• Neuroendocrinology of post-traumatic stress disorder.

  2010cited by this paper
• Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

  2009cited by this paper
• Status of Glucocorticoid Alterations in Post‐traumatic Stress Disorder

  2009cited by this paper
• Single prolonged stress: toward an animal model of posttraumatic stress disorder

  2009cited by this paper
• Adrenocorticotropic hormone elevates gene expression for catecholamine biosynthesis in rat superior cervical ganglia and locus coeruleus by an adrenal independent mechanism.

  2008cited by this paper
• The functional neuroanatomy of PTSD: a critical review.

  2008cited by this paper
• Early post-stressor intervention with high-dose corticosterone attenuates posttraumatic stress response in an animal model of posttraumatic stress disorder.

  2008cited by this paper
• Relevance of neuropeptide Y (NPY) in psychiatry.

  2007cited by this paper
• Physiology and gene regulation of the brain NPY Y1 receptor.

  2006cited by this paper
• Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats.

  2006cited by this paper
• Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis.

  2006cited by this paper
• Targeting melanocortin receptors as potential novel therapeutics.

  2006cited by this paper
• Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus.

  2005cited by this paper
• Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.

  2005cited by this paper
• Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD

  2004cited by this paper
• Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats.

  2004cited by this paper
• Noradrenergic Mechanisms in the Pathophysiology of Post-Traumatic Stress Disorder

  2004cited by this paper
• Regulation of neuropeptide Y release from hypothalamic slices by melanocortin-4 agonists and leptin.

  2000cited by this paper
• The Proopiomelanocortin System

  1999cited by this paper
• Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

  1999cited by this paper
• Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal proopiomelanocortin-derived peptides in the rat.

  1995cited by this paper
• Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein.

  1992cited by this paper
• Cloned human neuropeptide Y receptor couples to two different second messenger systems.

  1992cited by this paper

• Activation of trace amine-associated receptor 1 ameliorates PTSD-like symptoms.

  2024cites this paper
• The mind–skin connection: A narrative review exploring the link between inflammatory skin diseases and psychological stress

  2024cites this paper
• Cross talk about the role of Neuropeptide Y in CNS disorders and diseases.

  2023cites this paper
• MC4R in Central and Peripheral Systems

  2023cites this paper
• The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs

  2023cites this paper
• The Genetic Basis of Future Pharmacological Strategies for the Management of Comorbid Obesity and Depression: A Scoping Review

  2023cites this paper
• Protective Role and Functional Engineering of Neuropeptides in Depression and Anxiety: An Overview

  2023cites this paper
• Collateralizing ventral subiculum melanocortin 4 receptor circuits regulate energy balance and food motivation

  2023cites this paper
• Intranasal administration of Neuropeptide Y significantly antagonized stress-induced colonic dysmotility via central GABAA receptors in male rats.

  2022cites this paper
• Melanocortin-4 receptor signaling in the central amygdala mediates chronic inflammatory pain effects on nociception.

  2022cites this paper
• A thalamic circuit facilitates stress susceptibility via melanocortin 4 receptor‐mediated activation of nucleus accumbens shell

  2022cites this paper
• Noradrenergic modulation of stress resilience.

  2022cites this paper
• Transient receptor potential ankyrin 1 ion channel expressed by the Edinger-Westphal nucleus contributes to stress adaptation in murine model of posttraumatic stress disorder

  2022cites this paper
• Intranasal neuropeptide Y is most effective in some aspects of acute stress compared to melatonin, oxytocin and orexin

  2022cites this paper
• Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development

  2022cites this paper
• Investigating the role of the central melanocortin system in stress and stress-related disorders.

  2022cites this paper
• Antidepressant Effect of Neuropeptide Y in Models of Acute and Chronic Stress

  2022cites this paper
• Intranasal Administration of Neuropeptide Y Signi�cantly Antagonized Chronic Stress Responses via Central Gabaa Receptors in Male Rats

  2021influential citation
• Peptide-Liganded G Protein-Coupled Receptors as Neurotherapeutics.

  2020cites this paper
• Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD.

  2020cites this paper
• Neuropeptide Y in PTSD, MDD, and chronic stress: A systematic review and meta‐analysis

  2020cites this paper
• The Role of Genetic Variation of BMI, Body Composition, and Fat Distribution for Mental Traits and Disorders: A Look-Up and Mendelian Randomization Study

  2020cites this paper
• Effects of RU486 treatment after Single Prolonged Stress depend on the post-stress interval.

  2020cites this paper
• The role of the locus coeruleus in the generation of pathological anxiety

  2020cites this paper
• A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder

  2020cites this paper
• Single prolonged stress PTSD model triggers progressive severity of anxiety, altered gene expression in locus coeruleus and hypothalamus and effected sensitivity to NPY.

  2019cites this paper
• Single Prolonged Stress as a Prospective Model for Posttraumatic Stress Disorder in Females

  2019cites this paper
• Neuroendocrine Drivers of Risk and Resilience: The Influence of Metabolism & Mitochondria.

  2019cites this paper
• Modelling posttraumatic stress disorders in animals

  2019cites this paper
• Single-Prolonged Stress: A Review of Two Decades of Progress in a Rodent Model of Post-traumatic Stress Disorder

  2018cites this paper
• Potential of Intranasal Neuropeptide Y (NPY) and/or Melanocortin 4 Receptor (MC4R) Antagonists for Preventing or Treating PTSD.

  2018cites this paper
• Ultrastructural Characterization of Corticotropin-Releasing Factor and Neuropeptide Y in the Rat Locus Coeruleus: Anatomical Evidence for Putative Interactions.

  2018cites this paper
• Palmitoylation as a Functional Regulator of Neurotransmitter Receptors

  2018cites this paper
• Neuropeptide Y in Alcohol Addiction and Affective Disorders

  2017cites this paper
• NPY1 Receptor Agonist Modulates Development of Depressive-Like Behavior and Gene Expression in Hypothalamus in SPS Rodent PTSD Model

  2017cites this paper
• Antidepressant-like activity of venlafaxine and clonidine in mice exposed to single prolonged stress - A model of post-traumatic stress disorder. Pharmacodynamic and molecular docking studies.

  2017cites this paper
• Intra‐cerebral and intra‐nasal melanocortin‐4 receptor antagonist blocks withdrawal hyperalgesia in alcohol‐dependent rats

  2017cites this paper
• Adapting to Stress: Understanding the Neurobiology of Resilience

  2017cites this paper
• Adolescent Alcohol Exposure-Induced Changes in Alpha-Melanocyte Stimulating Hormone and Neuropeptide Y Pathways via Histone Acetylation in the Brain During Adulthood

  2017cites this paper
• Additional Antidepressant Pharmacotherapies According to a Neural Network

  2016cites this paper
• MicroRNA’s impact on neurotransmitter and neuropeptide systems: small but mighty mediators of anxiety

  2016cites this paper
• Neuropeptide Y: A stressful review.

  2016cites this paper
• Environmental enrichment induces behavioural disturbances in neuropeptide Y knockout mice

  2016cites this paper
• Prevention of Trauma and Stressor-Related Disorders: A Review

  2016cites this paper
• Transgenerational Social Stress, Immune Factors, Hormones, and Social Behavior

  2016cites this paper
• Exploring relationships between stress and olfaction as mediated by neuropeptide y

  2016cites this paper
• Running head: PRECLINICAL EVALUATIONS BLEND EXTRACT S. SYMPETALA P. OCCIDENTALIS Preclinical evaluations of the blend extract of Souroubea sympetala and Platanus occidentalis in rats: proposal of a potential novel treatment for post- traumatic stress disorder

  2015cites this paper
• Locus coeruleus response to single‐prolonged stress and early intervention with intranasal neuropeptide Y

  2015cites this paper